nodes	percent_of_prediction	percent_of_DWPC	metapath
Diazoxide—KCNMA1—kidney cancer	0.475	0.65	CbGaD
Diazoxide—CA2—kidney cancer	0.256	0.35	CbGaD
Diazoxide—SLC12A3—collecting duct of renal tubule—kidney cancer	0.0255	0.318	CbGeAlD
Diazoxide—SLC12A3—nephron—kidney cancer	0.0113	0.142	CbGeAlD
Diazoxide—CA2—collecting duct of renal tubule—kidney cancer	0.00867	0.108	CbGeAlD
Diazoxide—SLC12A3—nephron tubule—kidney cancer	0.00245	0.0306	CbGeAlD
Diazoxide—Chlorothiazide—CA2—kidney cancer	0.00232	1	CrCbGaD
Diazoxide—SLC12A3—renal system—kidney cancer	0.00222	0.0278	CbGeAlD
Diazoxide—SLC12A3—kidney—kidney cancer	0.00215	0.0269	CbGeAlD
Diazoxide—SLC12A3—cortex of kidney—kidney cancer	0.00209	0.0262	CbGeAlD
Diazoxide—GLUL—nephron tubule—kidney cancer	0.00182	0.0228	CbGeAlD
Diazoxide—GLUL—renal system—kidney cancer	0.00166	0.0207	CbGeAlD
Diazoxide—GLUL—kidney—kidney cancer	0.0016	0.02	CbGeAlD
Diazoxide—GLUL—cortex of kidney—kidney cancer	0.00156	0.0195	CbGeAlD
Diazoxide—KCNMA1—renal system—kidney cancer	0.00154	0.0192	CbGeAlD
Diazoxide—GLUL—gonad—kidney cancer	0.00149	0.0186	CbGeAlD
Diazoxide—ABCC8—renal system—kidney cancer	0.00143	0.0179	CbGeAlD
Diazoxide—ABCC8—kidney—kidney cancer	0.00139	0.0173	CbGeAlD
Diazoxide—KCNMA1—gonad—kidney cancer	0.00138	0.0172	CbGeAlD
Diazoxide—CA1—renal system—kidney cancer	0.00117	0.0146	CbGeAlD
Diazoxide—CA1—kidney—kidney cancer	0.00113	0.0141	CbGeAlD
Diazoxide—ATP1A1—nephron tubule—kidney cancer	0.00109	0.0136	CbGeAlD
Diazoxide—ATP1A1—renal system—kidney cancer	0.000988	0.0124	CbGeAlD
Diazoxide—ATP1A1—kidney—kidney cancer	0.000955	0.0119	CbGeAlD
Diazoxide—ATP1A1—cortex of kidney—kidney cancer	0.00093	0.0116	CbGeAlD
Diazoxide—ATP1A1—gonad—kidney cancer	0.000886	0.0111	CbGeAlD
Diazoxide—ATP1A1—cardiac atrium—kidney cancer	0.000885	0.0111	CbGeAlD
Diazoxide—CA2—nephron tubule—kidney cancer	0.000833	0.0104	CbGeAlD
Diazoxide—CA2—renal system—kidney cancer	0.000757	0.00947	CbGeAlD
Diazoxide—CA2—kidney—kidney cancer	0.000732	0.00915	CbGeAlD
Diazoxide—CA2—cortex of kidney—kidney cancer	0.000713	0.00891	CbGeAlD
Diazoxide—CA2—cardiac atrium—kidney cancer	0.000678	0.00848	CbGeAlD
Diazoxide—KCNJ11—Integration of energy metabolism—SLC2A1—kidney cancer	0.000225	0.00427	CbGpPWpGaD
Diazoxide—GLUL—TNF alpha Signaling Pathway—RAF1—kidney cancer	0.000224	0.00425	CbGpPWpGaD
Diazoxide—GLUL—Neuronal System—BCHE—kidney cancer	0.000216	0.0041	CbGpPWpGaD
Diazoxide—Body temperature increased—Everolimus—kidney cancer	0.00021	0.00157	CcSEcCtD
Diazoxide—Abdominal pain—Everolimus—kidney cancer	0.00021	0.00157	CcSEcCtD
Diazoxide—Fluid retention—Doxorubicin—kidney cancer	0.00021	0.00157	CcSEcCtD
Diazoxide—Haemorrhage—Paclitaxel—kidney cancer	0.00021	0.00157	CcSEcCtD
Diazoxide—Gastrointestinal pain—Erlotinib—kidney cancer	0.000209	0.00157	CcSEcCtD
Diazoxide—Abdominal discomfort—Capecitabine—kidney cancer	0.000206	0.00155	CcSEcCtD
Diazoxide—Leukopenia—Vincristine—kidney cancer	0.000206	0.00154	CcSEcCtD
Diazoxide—Thrombocytopenia—Dactinomycin—kidney cancer	0.000206	0.00154	CcSEcCtD
Diazoxide—Abdominal pain—Erlotinib—kidney cancer	0.000203	0.00152	CcSEcCtD
Diazoxide—Body temperature increased—Erlotinib—kidney cancer	0.000203	0.00152	CcSEcCtD
Diazoxide—Ill-defined disorder—Gemcitabine—kidney cancer	0.000202	0.00152	CcSEcCtD
Diazoxide—Insomnia—Sunitinib—kidney cancer	0.000201	0.0015	CcSEcCtD
Diazoxide—Decreased appetite—Sorafenib—kidney cancer	0.0002	0.0015	CcSEcCtD
Diazoxide—Anorexia—Dactinomycin—kidney cancer	0.0002	0.0015	CcSEcCtD
Diazoxide—Nausea—Pazopanib—kidney cancer	0.0002	0.0015	CcSEcCtD
Diazoxide—Paraesthesia—Sunitinib—kidney cancer	0.000199	0.00149	CcSEcCtD
Diazoxide—Hypertension—Vincristine—kidney cancer	0.000198	0.00149	CcSEcCtD
Diazoxide—Pain—Sorafenib—kidney cancer	0.000197	0.00148	CcSEcCtD
Diazoxide—Malaise—Gemcitabine—kidney cancer	0.000197	0.00147	CcSEcCtD
Diazoxide—Hypersensitivity—Vinblastine—kidney cancer	0.000196	0.00147	CcSEcCtD
Diazoxide—Weight increased—Capecitabine—kidney cancer	0.000196	0.00147	CcSEcCtD
Diazoxide—Hypersensitivity—Everolimus—kidney cancer	0.000196	0.00147	CcSEcCtD
Diazoxide—GLUL—TNF alpha Signaling Pathway—JUN—kidney cancer	0.000195	0.00371	CbGpPWpGaD
Diazoxide—Leukopenia—Gemcitabine—kidney cancer	0.000195	0.00146	CcSEcCtD
Diazoxide—Flushing—Paclitaxel—kidney cancer	0.000195	0.00146	CcSEcCtD
Diazoxide—GLUL—Metabolism—ACY1—kidney cancer	0.000194	0.00368	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000194	0.00368	CbGpPWpGaD
Diazoxide—Hyperglycaemia—Capecitabine—kidney cancer	0.000194	0.00145	CcSEcCtD
Diazoxide—Decreased appetite—Sunitinib—kidney cancer	0.000193	0.00145	CcSEcCtD
Diazoxide—Asthenia—Vinblastine—kidney cancer	0.000191	0.00143	CcSEcCtD
Diazoxide—Asthenia—Everolimus—kidney cancer	0.00019	0.00143	CcSEcCtD
Diazoxide—Pain—Sunitinib—kidney cancer	0.00019	0.00142	CcSEcCtD
Diazoxide—Gastrointestinal pain—Sorafenib—kidney cancer	0.000188	0.00141	CcSEcCtD
Diazoxide—Hypertension—Gemcitabine—kidney cancer	0.000188	0.00141	CcSEcCtD
Diazoxide—Lymphadenopathy—Doxorubicin—kidney cancer	0.000188	0.00141	CcSEcCtD
Diazoxide—Pruritus—Everolimus—kidney cancer	0.000188	0.00141	CcSEcCtD
Diazoxide—Oedema—Vincristine—kidney cancer	0.000188	0.00141	CcSEcCtD
Diazoxide—Chest pain—Gemcitabine—kidney cancer	0.000186	0.00139	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—KIT—kidney cancer	0.000185	0.0035	CbGpPWpGaD
Diazoxide—Asthenia—Erlotinib—kidney cancer	0.000184	0.00138	CcSEcCtD
Diazoxide—Thrombocytopenia—Vincristine—kidney cancer	0.000184	0.00138	CcSEcCtD
Diazoxide—Discomfort—Gemcitabine—kidney cancer	0.000183	0.00138	CcSEcCtD
Diazoxide—Haematuria—Capecitabine—kidney cancer	0.000183	0.00137	CcSEcCtD
Diazoxide—Decreased appetite—Dactinomycin—kidney cancer	0.000183	0.00137	CcSEcCtD
Diazoxide—Diarrhoea—Vinblastine—kidney cancer	0.000182	0.00137	CcSEcCtD
Diazoxide—Abdominal pain—Sorafenib—kidney cancer	0.000182	0.00137	CcSEcCtD
Diazoxide—Body temperature increased—Sorafenib—kidney cancer	0.000182	0.00137	CcSEcCtD
Diazoxide—Diarrhoea—Everolimus—kidney cancer	0.000182	0.00136	CcSEcCtD
Diazoxide—Gastrointestinal pain—Sunitinib—kidney cancer	0.000181	0.00136	CcSEcCtD
Diazoxide—Hyperhidrosis—Vincristine—kidney cancer	0.000181	0.00136	CcSEcCtD
Diazoxide—Pruritus—Erlotinib—kidney cancer	0.000181	0.00136	CcSEcCtD
Diazoxide—KCNMA1—Hemostasis—ANXA2—kidney cancer	0.000181	0.00343	CbGpPWpGaD
Diazoxide—Pain—Dactinomycin—kidney cancer	0.00018	0.00135	CcSEcCtD
Diazoxide—Vascular purpura—Doxorubicin—kidney cancer	0.000179	0.00134	CcSEcCtD
Diazoxide—KCNMA1—Circadian rythm related genes—EGR1—kidney cancer	0.000179	0.00339	CbGpPWpGaD
Diazoxide—Anorexia—Vincristine—kidney cancer	0.000179	0.00134	CcSEcCtD
Diazoxide—KCNMA1—Neuronal System—ACHE—kidney cancer	0.000179	0.00338	CbGpPWpGaD
Diazoxide—Oedema—Gemcitabine—kidney cancer	0.000178	0.00133	CcSEcCtD
Diazoxide—Dizziness—Vinblastine—kidney cancer	0.000176	0.00132	CcSEcCtD
Diazoxide—Dizziness—Everolimus—kidney cancer	0.000176	0.00132	CcSEcCtD
Diazoxide—Body temperature increased—Sunitinib—kidney cancer	0.000175	0.00131	CcSEcCtD
Diazoxide—Abdominal pain—Sunitinib—kidney cancer	0.000175	0.00131	CcSEcCtD
Diazoxide—Diarrhoea—Erlotinib—kidney cancer	0.000175	0.00131	CcSEcCtD
Diazoxide—Hypotension—Vincristine—kidney cancer	0.000175	0.00131	CcSEcCtD
Diazoxide—Thrombocytopenia—Gemcitabine—kidney cancer	0.000174	0.00131	CcSEcCtD
Diazoxide—Feeling abnormal—Dactinomycin—kidney cancer	0.000173	0.0013	CcSEcCtD
Diazoxide—Haemoglobin—Capecitabine—kidney cancer	0.000173	0.0013	CcSEcCtD
Diazoxide—Haemorrhage—Capecitabine—kidney cancer	0.000172	0.00129	CcSEcCtD
Diazoxide—Vision blurred—Paclitaxel—kidney cancer	0.000172	0.00129	CcSEcCtD
Diazoxide—Hyperhidrosis—Gemcitabine—kidney cancer	0.000172	0.00129	CcSEcCtD
Diazoxide—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000172	0.00129	CcSEcCtD
Diazoxide—ABCC8—Neuronal System—KCNMA1—kidney cancer	0.000172	0.00325	CbGpPWpGaD
Diazoxide—SLC12A3—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000171	0.00325	CbGpPWpGaD
Diazoxide—Hypersensitivity—Sorafenib—kidney cancer	0.00017	0.00127	CcSEcCtD
Diazoxide—Insomnia—Vincristine—kidney cancer	0.00017	0.00127	CcSEcCtD
Diazoxide—Anorexia—Gemcitabine—kidney cancer	0.00017	0.00127	CcSEcCtD
Diazoxide—Vomiting—Vinblastine—kidney cancer	0.000169	0.00127	CcSEcCtD
Diazoxide—Dizziness—Erlotinib—kidney cancer	0.000169	0.00127	CcSEcCtD
Diazoxide—Ill-defined disorder—Paclitaxel—kidney cancer	0.000169	0.00127	CcSEcCtD
Diazoxide—Vomiting—Everolimus—kidney cancer	0.000169	0.00127	CcSEcCtD
Diazoxide—Paraesthesia—Vincristine—kidney cancer	0.000168	0.00126	CcSEcCtD
Diazoxide—Rash—Everolimus—kidney cancer	0.000167	0.00126	CcSEcCtD
Diazoxide—Dermatitis—Everolimus—kidney cancer	0.000167	0.00125	CcSEcCtD
Diazoxide—Headache—Vinblastine—kidney cancer	0.000167	0.00125	CcSEcCtD
Diazoxide—KCNJ11—Neuronal System—KCNMA1—kidney cancer	0.000166	0.00316	CbGpPWpGaD
Diazoxide—Purpura—Doxorubicin—kidney cancer	0.000166	0.00125	CcSEcCtD
Diazoxide—Headache—Everolimus—kidney cancer	0.000166	0.00125	CcSEcCtD
Diazoxide—Hypotension—Gemcitabine—kidney cancer	0.000166	0.00125	CcSEcCtD
Diazoxide—Abdominal pain—Dactinomycin—kidney cancer	0.000166	0.00124	CcSEcCtD
Diazoxide—Body temperature increased—Dactinomycin—kidney cancer	0.000166	0.00124	CcSEcCtD
Diazoxide—SLC12A3—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000166	0.00314	CbGpPWpGaD
Diazoxide—Asthenia—Sorafenib—kidney cancer	0.000165	0.00124	CcSEcCtD
Diazoxide—GLUL—Metabolism—PDHB—kidney cancer	0.000165	0.00313	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000165	0.00313	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000165	0.00313	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000165	0.00313	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000165	0.00313	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000165	0.00313	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000165	0.00313	CbGpPWpGaD
Diazoxide—Malaise—Paclitaxel—kidney cancer	0.000165	0.00123	CcSEcCtD
Diazoxide—Leukopenia—Paclitaxel—kidney cancer	0.000163	0.00123	CcSEcCtD
Diazoxide—Hypersensitivity—Sunitinib—kidney cancer	0.000163	0.00123	CcSEcCtD
Diazoxide—Decreased appetite—Vincristine—kidney cancer	0.000163	0.00122	CcSEcCtD
Diazoxide—Pruritus—Sorafenib—kidney cancer	0.000163	0.00122	CcSEcCtD
Diazoxide—Vomiting—Erlotinib—kidney cancer	0.000163	0.00122	CcSEcCtD
Diazoxide—Rash—Erlotinib—kidney cancer	0.000162	0.00121	CcSEcCtD
Diazoxide—GLUL—TNF alpha Signaling Pathway—MAPK3—kidney cancer	0.000162	0.00306	CbGpPWpGaD
Diazoxide—Dermatitis—Erlotinib—kidney cancer	0.000161	0.00121	CcSEcCtD
Diazoxide—Palpitations—Paclitaxel—kidney cancer	0.000161	0.00121	CcSEcCtD
Diazoxide—Insomnia—Gemcitabine—kidney cancer	0.000161	0.00121	CcSEcCtD
Diazoxide—Headache—Erlotinib—kidney cancer	0.00016	0.0012	CcSEcCtD
Diazoxide—Pain—Vincristine—kidney cancer	0.00016	0.0012	CcSEcCtD
Diazoxide—Diplopia—Doxorubicin—kidney cancer	0.00016	0.0012	CcSEcCtD
Diazoxide—Paraesthesia—Gemcitabine—kidney cancer	0.00016	0.0012	CcSEcCtD
Diazoxide—Flushing—Capecitabine—kidney cancer	0.00016	0.0012	CcSEcCtD
Diazoxide—Asthenia—Sunitinib—kidney cancer	0.000159	0.00119	CcSEcCtD
Diazoxide—Nausea—Vinblastine—kidney cancer	0.000158	0.00119	CcSEcCtD
Diazoxide—Nausea—Everolimus—kidney cancer	0.000158	0.00118	CcSEcCtD
Diazoxide—Diarrhoea—Sorafenib—kidney cancer	0.000158	0.00118	CcSEcCtD
Diazoxide—Hypertension—Paclitaxel—kidney cancer	0.000158	0.00118	CcSEcCtD
Diazoxide—Pruritus—Sunitinib—kidney cancer	0.000157	0.00118	CcSEcCtD
Diazoxide—KCNMA1—Neuronal System—BCHE—kidney cancer	0.000156	0.00295	CbGpPWpGaD
Diazoxide—Chest pain—Paclitaxel—kidney cancer	0.000155	0.00117	CcSEcCtD
Diazoxide—GLUL—Metabolism—CCBL1—kidney cancer	0.000155	0.00295	CbGpPWpGaD
Diazoxide—Anxiety—Paclitaxel—kidney cancer	0.000155	0.00116	CcSEcCtD
Diazoxide—Decreased appetite—Gemcitabine—kidney cancer	0.000155	0.00116	CcSEcCtD
Diazoxide—Hypersensitivity—Dactinomycin—kidney cancer	0.000155	0.00116	CcSEcCtD
Diazoxide—GLUL—TNF alpha Signaling Pathway—MAPK1—kidney cancer	0.000154	0.00291	CbGpPWpGaD
Diazoxide—Discomfort—Paclitaxel—kidney cancer	0.000154	0.00115	CcSEcCtD
Diazoxide—Gastrointestinal pain—Vincristine—kidney cancer	0.000153	0.00115	CcSEcCtD
Diazoxide—Dizziness—Sorafenib—kidney cancer	0.000152	0.00114	CcSEcCtD
Diazoxide—Pain—Gemcitabine—kidney cancer	0.000152	0.00114	CcSEcCtD
Diazoxide—Nausea—Erlotinib—kidney cancer	0.000152	0.00114	CcSEcCtD
Diazoxide—Diarrhoea—Sunitinib—kidney cancer	0.000152	0.00114	CcSEcCtD
Diazoxide—Asthenia—Dactinomycin—kidney cancer	0.000151	0.00113	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—CDKN2A—kidney cancer	0.00015	0.00284	CbGpPWpGaD
Diazoxide—Oedema—Paclitaxel—kidney cancer	0.000149	0.00112	CcSEcCtD
Diazoxide—Body temperature increased—Vincristine—kidney cancer	0.000148	0.00111	CcSEcCtD
Diazoxide—Abdominal pain—Vincristine—kidney cancer	0.000148	0.00111	CcSEcCtD
Diazoxide—Dizziness—Sunitinib—kidney cancer	0.000147	0.0011	CcSEcCtD
Diazoxide—Feeling abnormal—Gemcitabine—kidney cancer	0.000147	0.0011	CcSEcCtD
Diazoxide—Vomiting—Sorafenib—kidney cancer	0.000147	0.0011	CcSEcCtD
Diazoxide—Hypokalaemia—Doxorubicin—kidney cancer	0.000146	0.00109	CcSEcCtD
Diazoxide—Thrombocytopenia—Paclitaxel—kidney cancer	0.000146	0.00109	CcSEcCtD
Diazoxide—Tachycardia—Paclitaxel—kidney cancer	0.000145	0.00109	CcSEcCtD
Diazoxide—Rash—Sorafenib—kidney cancer	0.000145	0.00109	CcSEcCtD
Diazoxide—Dermatitis—Sorafenib—kidney cancer	0.000145	0.00109	CcSEcCtD
Diazoxide—GLUL—TNF alpha Signaling Pathway—KRAS—kidney cancer	0.000145	0.00275	CbGpPWpGaD
Diazoxide—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000144	0.00108	CcSEcCtD
Diazoxide—Headache—Sorafenib—kidney cancer	0.000144	0.00108	CcSEcCtD
Diazoxide—GLUL—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000144	0.00273	CbGpPWpGaD
Diazoxide—Hyperhidrosis—Paclitaxel—kidney cancer	0.000144	0.00108	CcSEcCtD
Diazoxide—Diarrhoea—Dactinomycin—kidney cancer	0.000144	0.00108	CcSEcCtD
Diazoxide—Anorexia—Paclitaxel—kidney cancer	0.000142	0.00107	CcSEcCtD
Diazoxide—Vision blurred—Capecitabine—kidney cancer	0.000141	0.00106	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—CD4—kidney cancer	0.000141	0.00268	CbGpPWpGaD
Diazoxide—Vomiting—Sunitinib—kidney cancer	0.000141	0.00106	CcSEcCtD
Diazoxide—Body temperature increased—Gemcitabine—kidney cancer	0.000141	0.00105	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—PTGS2—kidney cancer	0.00014	0.00266	CbGpPWpGaD
Diazoxide—Rash—Sunitinib—kidney cancer	0.00014	0.00105	CcSEcCtD
Diazoxide—Dermatitis—Sunitinib—kidney cancer	0.00014	0.00105	CcSEcCtD
Diazoxide—Hypotension—Paclitaxel—kidney cancer	0.000139	0.00104	CcSEcCtD
Diazoxide—Ill-defined disorder—Capecitabine—kidney cancer	0.000139	0.00104	CcSEcCtD
Diazoxide—Headache—Sunitinib—kidney cancer	0.000139	0.00104	CcSEcCtD
Diazoxide—Hypersensitivity—Vincristine—kidney cancer	0.000138	0.00104	CcSEcCtD
Diazoxide—Eosinophilia—Doxorubicin—kidney cancer	0.000137	0.00103	CcSEcCtD
Diazoxide—Nausea—Sorafenib—kidney cancer	0.000137	0.00103	CcSEcCtD
Diazoxide—Pancreatitis—Doxorubicin—kidney cancer	0.000136	0.00102	CcSEcCtD
Diazoxide—Malaise—Capecitabine—kidney cancer	0.000135	0.00101	CcSEcCtD
Diazoxide—Insomnia—Paclitaxel—kidney cancer	0.000135	0.00101	CcSEcCtD
Diazoxide—GLUL—Metabolism—GLIPR1—kidney cancer	0.000135	0.00255	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PPAT—kidney cancer	0.000135	0.00255	CbGpPWpGaD
Diazoxide—Asthenia—Vincristine—kidney cancer	0.000135	0.00101	CcSEcCtD
Diazoxide—Leukopenia—Capecitabine—kidney cancer	0.000134	0.00101	CcSEcCtD
Diazoxide—Paraesthesia—Paclitaxel—kidney cancer	0.000134	0.001	CcSEcCtD
Diazoxide—Vomiting—Dactinomycin—kidney cancer	0.000133	0.001	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—CDKN1B—kidney cancer	0.000133	0.00252	CbGpPWpGaD
Diazoxide—Palpitations—Capecitabine—kidney cancer	0.000132	0.000993	CcSEcCtD
Diazoxide—Rash—Dactinomycin—kidney cancer	0.000132	0.000993	CcSEcCtD
Diazoxide—Nausea—Sunitinib—kidney cancer	0.000132	0.000988	CcSEcCtD
Diazoxide—KCNMA1—Hemostasis—GRB7—kidney cancer	0.000131	0.00248	CbGpPWpGaD
Diazoxide—Decreased appetite—Paclitaxel—kidney cancer	0.00013	0.000971	CcSEcCtD
Diazoxide—Hypertension—Capecitabine—kidney cancer	0.000129	0.00097	CcSEcCtD
Diazoxide—Diarrhoea—Vincristine—kidney cancer	0.000128	0.000963	CcSEcCtD
Diazoxide—Asthenia—Gemcitabine—kidney cancer	0.000128	0.000958	CcSEcCtD
Diazoxide—Chest pain—Capecitabine—kidney cancer	0.000128	0.000957	CcSEcCtD
Diazoxide—Pain—Paclitaxel—kidney cancer	0.000127	0.000956	CcSEcCtD
Diazoxide—Anxiety—Capecitabine—kidney cancer	0.000127	0.000953	CcSEcCtD
Diazoxide—ABCC8—Neuronal System—ACHE—kidney cancer	0.000127	0.00241	CbGpPWpGaD
Diazoxide—CA1—C-MYB transcription factor network—CCND1—kidney cancer	0.000127	0.0024	CbGpPWpGaD
Diazoxide—Weight increased—Doxorubicin—kidney cancer	0.000126	0.000946	CcSEcCtD
Diazoxide—Discomfort—Capecitabine—kidney cancer	0.000126	0.000945	CcSEcCtD
Diazoxide—Pruritus—Gemcitabine—kidney cancer	0.000126	0.000944	CcSEcCtD
Diazoxide—GLUL—Metabolism—APRT—kidney cancer	0.000125	0.00237	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—FH—kidney cancer	0.000125	0.00237	CbGpPWpGaD
Diazoxide—Hyperglycaemia—Doxorubicin—kidney cancer	0.000125	0.000938	CcSEcCtD
Diazoxide—Nausea—Dactinomycin—kidney cancer	0.000125	0.000935	CcSEcCtD
Diazoxide—Dizziness—Vincristine—kidney cancer	0.000124	0.00093	CcSEcCtD
Diazoxide—KCNJ11—Neuronal System—ACHE—kidney cancer	0.000123	0.00233	CbGpPWpGaD
Diazoxide—Feeling abnormal—Paclitaxel—kidney cancer	0.000123	0.000921	CcSEcCtD
Diazoxide—Oedema—Capecitabine—kidney cancer	0.000122	0.000917	CcSEcCtD
Diazoxide—CA2—Metabolism—ACY1—kidney cancer	0.000122	0.00231	CbGpPWpGaD
Diazoxide—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000122	0.000914	CcSEcCtD
Diazoxide—Diarrhoea—Gemcitabine—kidney cancer	0.000122	0.000913	CcSEcCtD
Diazoxide—KCNMA1—Hemostasis—ITPR2—kidney cancer	0.000122	0.00231	CbGpPWpGaD
Diazoxide—GLUL—Transmission across Chemical Synapses—RAF1—kidney cancer	0.00012	0.00228	CbGpPWpGaD
Diazoxide—Thrombocytopenia—Capecitabine—kidney cancer	0.00012	0.000898	CcSEcCtD
Diazoxide—Tachycardia—Capecitabine—kidney cancer	0.000119	0.000895	CcSEcCtD
Diazoxide—Vomiting—Vincristine—kidney cancer	0.000119	0.000894	CcSEcCtD
Diazoxide—Sweating—Doxorubicin—kidney cancer	0.000118	0.000888	CcSEcCtD
Diazoxide—Rash—Vincristine—kidney cancer	0.000118	0.000887	CcSEcCtD
Diazoxide—Hyperhidrosis—Capecitabine—kidney cancer	0.000118	0.000886	CcSEcCtD
Diazoxide—Dermatitis—Vincristine—kidney cancer	0.000118	0.000886	CcSEcCtD
Diazoxide—Haematuria—Doxorubicin—kidney cancer	0.000118	0.000884	CcSEcCtD
Diazoxide—Body temperature increased—Paclitaxel—kidney cancer	0.000118	0.000883	CcSEcCtD
Diazoxide—Abdominal pain—Paclitaxel—kidney cancer	0.000118	0.000883	CcSEcCtD
Diazoxide—GLUL—Metabolism—GPC3—kidney cancer	0.000118	0.00223	CbGpPWpGaD
Diazoxide—Headache—Vincristine—kidney cancer	0.000118	0.000881	CcSEcCtD
Diazoxide—CA1—Metabolism—ACY1—kidney cancer	0.000117	0.00221	CbGpPWpGaD
Diazoxide—Anorexia—Capecitabine—kidney cancer	0.000117	0.000874	CcSEcCtD
Diazoxide—GLUL—Metabolism—CA2—kidney cancer	0.000115	0.00217	CbGpPWpGaD
Diazoxide—Hypotension—Capecitabine—kidney cancer	0.000114	0.000857	CcSEcCtD
Diazoxide—Vomiting—Gemcitabine—kidney cancer	0.000113	0.000849	CcSEcCtD
Diazoxide—Rash—Gemcitabine—kidney cancer	0.000112	0.000841	CcSEcCtD
Diazoxide—Dermatitis—Gemcitabine—kidney cancer	0.000112	0.000841	CcSEcCtD
Diazoxide—GLUL—Metabolism—ALAD—kidney cancer	0.000112	0.00212	CbGpPWpGaD
Diazoxide—Haemoglobin—Doxorubicin—kidney cancer	0.000111	0.000836	CcSEcCtD
Diazoxide—Headache—Gemcitabine—kidney cancer	0.000111	0.000836	CcSEcCtD
Diazoxide—Nausea—Vincristine—kidney cancer	0.000111	0.000836	CcSEcCtD
Diazoxide—ABCC8—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000111	0.00211	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000111	0.00211	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000111	0.00211	CbGpPWpGaD
Diazoxide—Haemorrhage—Doxorubicin—kidney cancer	0.000111	0.000832	CcSEcCtD
Diazoxide—ABCC8—Neuronal System—BCHE—kidney cancer	0.000111	0.0021	CbGpPWpGaD
Diazoxide—Insomnia—Capecitabine—kidney cancer	0.000111	0.000829	CcSEcCtD
Diazoxide—GLUL—Neuronal System—BRAF—kidney cancer	0.00011	0.00209	CbGpPWpGaD
Diazoxide—Paraesthesia—Capecitabine—kidney cancer	0.00011	0.000823	CcSEcCtD
Diazoxide—Hypersensitivity—Paclitaxel—kidney cancer	0.00011	0.000823	CcSEcCtD
Diazoxide—GLUL—Metabolism—ST3GAL2—kidney cancer	0.000109	0.00207	CbGpPWpGaD
Diazoxide—ATP1A1—Ion channel transport—RAF1—kidney cancer	0.000108	0.00205	CbGpPWpGaD
Diazoxide—KCNJ11—Neuronal System—BCHE—kidney cancer	0.000107	0.00203	CbGpPWpGaD
Diazoxide—Asthenia—Paclitaxel—kidney cancer	0.000107	0.000802	CcSEcCtD
Diazoxide—GLUL—Metabolism—ALDH1A1—kidney cancer	0.000106	0.00202	CbGpPWpGaD
Diazoxide—Decreased appetite—Capecitabine—kidney cancer	0.000106	0.000797	CcSEcCtD
Diazoxide—Nausea—Gemcitabine—kidney cancer	0.000106	0.000793	CcSEcCtD
Diazoxide—Pruritus—Paclitaxel—kidney cancer	0.000105	0.000791	CcSEcCtD
Diazoxide—Pain—Capecitabine—kidney cancer	0.000105	0.000784	CcSEcCtD
Diazoxide—CA2—Metabolism—PDHB—kidney cancer	0.000104	0.00196	CbGpPWpGaD
Diazoxide—Flushing—Doxorubicin—kidney cancer	0.000103	0.000772	CcSEcCtD
Diazoxide—GLUL—Metabolism—PGK1—kidney cancer	0.000102	0.00194	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—SLC5A3—kidney cancer	0.000102	0.00194	CbGpPWpGaD
Diazoxide—Diarrhoea—Paclitaxel—kidney cancer	0.000102	0.000765	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—MYC—kidney cancer	0.000102	0.00192	CbGpPWpGaD
Diazoxide—Feeling abnormal—Capecitabine—kidney cancer	0.000101	0.000756	CcSEcCtD
Diazoxide—GLUL—Metabolism—LDHB—kidney cancer	0.0001	0.0019	CbGpPWpGaD
Diazoxide—Gastrointestinal pain—Capecitabine—kidney cancer	0.0001	0.00075	CcSEcCtD
Diazoxide—ABCC8—Metabolism—ACY1—kidney cancer	9.93e-05	0.00188	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PDHB—kidney cancer	9.93e-05	0.00188	CbGpPWpGaD
Diazoxide—Dizziness—Paclitaxel—kidney cancer	9.85e-05	0.000739	CcSEcCtD
Diazoxide—CA2—Metabolism—CCBL1—kidney cancer	9.74e-05	0.00185	CbGpPWpGaD
Diazoxide—Body temperature increased—Capecitabine—kidney cancer	9.66e-05	0.000725	CcSEcCtD
Diazoxide—Abdominal pain—Capecitabine—kidney cancer	9.66e-05	0.000725	CcSEcCtD
Diazoxide—KCNJ11—Metabolism—ACY1—kidney cancer	9.63e-05	0.00183	CbGpPWpGaD
Diazoxide—Vomiting—Paclitaxel—kidney cancer	9.47e-05	0.00071	CcSEcCtD
Diazoxide—Rash—Paclitaxel—kidney cancer	9.39e-05	0.000705	CcSEcCtD
Diazoxide—Dermatitis—Paclitaxel—kidney cancer	9.38e-05	0.000704	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—KRAS—kidney cancer	9.38e-05	0.00178	CbGpPWpGaD
Diazoxide—CA1—Metabolism—CCBL1—kidney cancer	9.34e-05	0.00177	CbGpPWpGaD
Diazoxide—Headache—Paclitaxel—kidney cancer	9.33e-05	0.0007	CcSEcCtD
Diazoxide—GLUL—Neuronal System—RAF1—kidney cancer	9.22e-05	0.00175	CbGpPWpGaD
Diazoxide—Vision blurred—Doxorubicin—kidney cancer	9.1e-05	0.000683	CcSEcCtD
Diazoxide—Hypersensitivity—Capecitabine—kidney cancer	9.01e-05	0.000676	CcSEcCtD
Diazoxide—Ill-defined disorder—Doxorubicin—kidney cancer	8.96e-05	0.000672	CcSEcCtD
Diazoxide—KCNMA1—Hemostasis—IFNA1—kidney cancer	8.92e-05	0.00169	CbGpPWpGaD
Diazoxide—Nausea—Paclitaxel—kidney cancer	8.85e-05	0.000664	CcSEcCtD
Diazoxide—Asthenia—Capecitabine—kidney cancer	8.77e-05	0.000658	CcSEcCtD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	8.71e-05	0.00165	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	8.71e-05	0.00165	CbGpPWpGaD
Diazoxide—Malaise—Doxorubicin—kidney cancer	8.71e-05	0.000653	CcSEcCtD
Diazoxide—GLUL—Metabolism—CA9—kidney cancer	8.68e-05	0.00165	CbGpPWpGaD
Diazoxide—Pruritus—Capecitabine—kidney cancer	8.65e-05	0.000649	CcSEcCtD
Diazoxide—Leukopenia—Doxorubicin—kidney cancer	8.64e-05	0.000648	CcSEcCtD
Diazoxide—Palpitations—Doxorubicin—kidney cancer	8.53e-05	0.00064	CcSEcCtD
Diazoxide—ABCC8—Metabolism—PDHB—kidney cancer	8.44e-05	0.0016	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PPAT—kidney cancer	8.44e-05	0.0016	CbGpPWpGaD
Diazoxide—CA2—Metabolism—GLIPR1—kidney cancer	8.44e-05	0.0016	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	8.41e-05	0.0016	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	8.41e-05	0.0016	CbGpPWpGaD
Diazoxide—Diarrhoea—Capecitabine—kidney cancer	8.37e-05	0.000627	CcSEcCtD
Diazoxide—Hypertension—Doxorubicin—kidney cancer	8.34e-05	0.000625	CcSEcCtD
Diazoxide—KCNMA1—Hemostasis—IFNA2—kidney cancer	8.31e-05	0.00157	CbGpPWpGaD
Diazoxide—GLUL—Transmission across Chemical Synapses—MAPK1—kidney cancer	8.26e-05	0.00157	CbGpPWpGaD
Diazoxide—Chest pain—Doxorubicin—kidney cancer	8.22e-05	0.000617	CcSEcCtD
Diazoxide—Anxiety—Doxorubicin—kidney cancer	8.19e-05	0.000614	CcSEcCtD
Diazoxide—KCNJ11—Metabolism—PDHB—kidney cancer	8.19e-05	0.00155	CbGpPWpGaD
Diazoxide—Discomfort—Doxorubicin—kidney cancer	8.12e-05	0.000609	CcSEcCtD
Diazoxide—CA1—Metabolism—GLIPR1—kidney cancer	8.1e-05	0.00153	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PPAT—kidney cancer	8.1e-05	0.00153	CbGpPWpGaD
Diazoxide—Dizziness—Capecitabine—kidney cancer	8.08e-05	0.000606	CcSEcCtD
Diazoxide—ABCC8—Metabolism—CCBL1—kidney cancer	7.94e-05	0.00151	CbGpPWpGaD
Diazoxide—KCNMA1—Neuronal System—BRAF—kidney cancer	7.94e-05	0.0015	CbGpPWpGaD
Diazoxide—Oedema—Doxorubicin—kidney cancer	7.88e-05	0.000591	CcSEcCtD
Diazoxide—CA2—Metabolism—FH—kidney cancer	7.85e-05	0.00149	CbGpPWpGaD
Diazoxide—CA2—Metabolism—APRT—kidney cancer	7.85e-05	0.00149	CbGpPWpGaD
Diazoxide—Vomiting—Capecitabine—kidney cancer	7.77e-05	0.000583	CcSEcCtD
Diazoxide—Thrombocytopenia—Doxorubicin—kidney cancer	7.72e-05	0.000579	CcSEcCtD
Diazoxide—Rash—Capecitabine—kidney cancer	7.71e-05	0.000578	CcSEcCtD
Diazoxide—Dermatitis—Capecitabine—kidney cancer	7.7e-05	0.000578	CcSEcCtD
Diazoxide—KCNJ11—Metabolism—CCBL1—kidney cancer	7.7e-05	0.00146	CbGpPWpGaD
Diazoxide—Tachycardia—Doxorubicin—kidney cancer	7.69e-05	0.000577	CcSEcCtD
Diazoxide—Headache—Capecitabine—kidney cancer	7.66e-05	0.000574	CcSEcCtD
Diazoxide—Hyperhidrosis—Doxorubicin—kidney cancer	7.62e-05	0.000571	CcSEcCtD
Diazoxide—CA1—Metabolism—APRT—kidney cancer	7.53e-05	0.00143	CbGpPWpGaD
Diazoxide—CA1—Metabolism—FH—kidney cancer	7.53e-05	0.00143	CbGpPWpGaD
Diazoxide—KCNMA1—Circadian rythm related genes—JUN—kidney cancer	7.51e-05	0.00142	CbGpPWpGaD
Diazoxide—Anorexia—Doxorubicin—kidney cancer	7.51e-05	0.000563	CcSEcCtD
Diazoxide—KCNMA1—Hemostasis—IGF2—kidney cancer	7.48e-05	0.00142	CbGpPWpGaD
Diazoxide—CA2—Metabolism—GPC3—kidney cancer	7.38e-05	0.0014	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—CRABP1—kidney cancer	7.38e-05	0.0014	CbGpPWpGaD
Diazoxide—Hypotension—Doxorubicin—kidney cancer	7.36e-05	0.000552	CcSEcCtD
Diazoxide—KCNMA1—Circadian rythm related genes—PTEN—kidney cancer	7.27e-05	0.00138	CbGpPWpGaD
Diazoxide—Nausea—Capecitabine—kidney cancer	7.26e-05	0.000545	CcSEcCtD
Diazoxide—Insomnia—Doxorubicin—kidney cancer	7.13e-05	0.000535	CcSEcCtD
Diazoxide—CA1—Metabolism—GPC3—kidney cancer	7.08e-05	0.00134	CbGpPWpGaD
Diazoxide—Paraesthesia—Doxorubicin—kidney cancer	7.08e-05	0.000531	CcSEcCtD
Diazoxide—CA2—Metabolism—ALAD—kidney cancer	7e-05	0.00133	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PPAT—kidney cancer	6.88e-05	0.00131	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—GLIPR1—kidney cancer	6.88e-05	0.00131	CbGpPWpGaD
Diazoxide—CA1—Metabolism—CA2—kidney cancer	6.88e-05	0.00131	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—ITPR2—kidney cancer	6.86e-05	0.0013	CbGpPWpGaD
Diazoxide—Decreased appetite—Doxorubicin—kidney cancer	6.85e-05	0.000514	CcSEcCtD
Diazoxide—CA2—Metabolism—ST3GAL2—kidney cancer	6.83e-05	0.00129	CbGpPWpGaD
Diazoxide—Pain—Doxorubicin—kidney cancer	6.74e-05	0.000505	CcSEcCtD
Diazoxide—CA1—Metabolism—ALAD—kidney cancer	6.71e-05	0.00127	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—GLIPR1—kidney cancer	6.68e-05	0.00127	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PPAT—kidney cancer	6.68e-05	0.00127	CbGpPWpGaD
Diazoxide—CA2—Metabolism—ALDH1A1—kidney cancer	6.68e-05	0.00127	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—ABCB1—kidney cancer	6.64e-05	0.00126	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	6.64e-05	0.00126	CbGpPWpGaD
Diazoxide—KCNMA1—Neuronal System—RAF1—kidney cancer	6.63e-05	0.00126	CbGpPWpGaD
Diazoxide—CA1—Metabolism—ST3GAL2—kidney cancer	6.55e-05	0.00124	CbGpPWpGaD
Diazoxide—Feeling abnormal—Doxorubicin—kidney cancer	6.49e-05	0.000487	CcSEcCtD
Diazoxide—Gastrointestinal pain—Doxorubicin—kidney cancer	6.44e-05	0.000483	CcSEcCtD
Diazoxide—CA2—Metabolism—PGK1—kidney cancer	6.4e-05	0.00121	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—APRT—kidney cancer	6.4e-05	0.00121	CbGpPWpGaD
Diazoxide—CA1—Metabolism—ALDH1A1—kidney cancer	6.4e-05	0.00121	CbGpPWpGaD
Diazoxide—CA2—Metabolism—SLC5A3—kidney cancer	6.4e-05	0.00121	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—FH—kidney cancer	6.4e-05	0.00121	CbGpPWpGaD
Diazoxide—GLUL—Neuronal System—MAPK1—kidney cancer	6.33e-05	0.0012	CbGpPWpGaD
Diazoxide—CA2—Metabolism—LDHB—kidney cancer	6.28e-05	0.00119	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—ACHE—kidney cancer	6.26e-05	0.00119	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—GSTT1—kidney cancer	6.26e-05	0.00119	CbGpPWpGaD
Diazoxide—Abdominal pain—Doxorubicin—kidney cancer	6.23e-05	0.000467	CcSEcCtD
Diazoxide—Body temperature increased—Doxorubicin—kidney cancer	6.23e-05	0.000467	CcSEcCtD
Diazoxide—KCNJ11—Metabolism—FH—kidney cancer	6.21e-05	0.00118	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—APRT—kidney cancer	6.21e-05	0.00118	CbGpPWpGaD
Diazoxide—CA1—Metabolism—SLC5A3—kidney cancer	6.14e-05	0.00116	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PGK1—kidney cancer	6.14e-05	0.00116	CbGpPWpGaD
Diazoxide—CA1—Metabolism—LDHB—kidney cancer	6.02e-05	0.00114	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—GPC3—kidney cancer	6.02e-05	0.00114	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—SCARB1—kidney cancer	5.92e-05	0.00112	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—SLC5A5—kidney cancer	5.87e-05	0.00111	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PTGS1—kidney cancer	5.86e-05	0.00111	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—CA2—kidney cancer	5.85e-05	0.00111	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—GPC3—kidney cancer	5.83e-05	0.00111	CbGpPWpGaD
Diazoxide—Hypersensitivity—Doxorubicin—kidney cancer	5.81e-05	0.000435	CcSEcCtD
Diazoxide—GLUL—Metabolism—PSMD7—kidney cancer	5.75e-05	0.00109	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—ALAD—kidney cancer	5.7e-05	0.00108	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—CA2—kidney cancer	5.68e-05	0.00108	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—SLC2A1—kidney cancer	5.67e-05	0.00108	CbGpPWpGaD
Diazoxide—Asthenia—Doxorubicin—kidney cancer	5.65e-05	0.000424	CcSEcCtD
Diazoxide—ABCC8—Neuronal System—BRAF—kidney cancer	5.65e-05	0.00107	CbGpPWpGaD
Diazoxide—Pruritus—Doxorubicin—kidney cancer	5.58e-05	0.000418	CcSEcCtD
Diazoxide—ABCC8—Metabolism—ST3GAL2—kidney cancer	5.57e-05	0.00106	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—ALAD—kidney cancer	5.53e-05	0.00105	CbGpPWpGaD
Diazoxide—KCNJ11—Neuronal System—BRAF—kidney cancer	5.47e-05	0.00104	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—BCHE—kidney cancer	5.45e-05	0.00103	CbGpPWpGaD
Diazoxide—CA2—Metabolism—CA9—kidney cancer	5.44e-05	0.00103	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—ALDH1A1—kidney cancer	5.44e-05	0.00103	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—ST3GAL2—kidney cancer	5.4e-05	0.00102	CbGpPWpGaD
Diazoxide—Diarrhoea—Doxorubicin—kidney cancer	5.39e-05	0.000404	CcSEcCtD
Diazoxide—GLUL—Metabolism—SLC5A5—kidney cancer	5.38e-05	0.00102	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—ALDH1A1—kidney cancer	5.28e-05	0.001	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PGK1—kidney cancer	5.22e-05	0.000989	CbGpPWpGaD
Diazoxide—CA1—Metabolism—CA9—kidney cancer	5.22e-05	0.000989	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—SLC5A3—kidney cancer	5.22e-05	0.000989	CbGpPWpGaD
Diazoxide—Dizziness—Doxorubicin—kidney cancer	5.21e-05	0.000391	CcSEcCtD
Diazoxide—GLUL—Metabolism—SLC2A1—kidney cancer	5.2e-05	0.000986	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—LDHB—kidney cancer	5.12e-05	0.00097	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—SLC5A3—kidney cancer	5.06e-05	0.000959	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PGK1—kidney cancer	5.06e-05	0.000959	CbGpPWpGaD
Diazoxide—Vomiting—Doxorubicin—kidney cancer	5.01e-05	0.000376	CcSEcCtD
Diazoxide—Rash—Doxorubicin—kidney cancer	4.97e-05	0.000373	CcSEcCtD
Diazoxide—Dermatitis—Doxorubicin—kidney cancer	4.96e-05	0.000372	CcSEcCtD
Diazoxide—KCNJ11—Metabolism—LDHB—kidney cancer	4.96e-05	0.000941	CbGpPWpGaD
Diazoxide—KCNMA1—Circadian rythm related genes—TP53—kidney cancer	4.96e-05	0.00094	CbGpPWpGaD
Diazoxide—Headache—Doxorubicin—kidney cancer	4.94e-05	0.00037	CcSEcCtD
Diazoxide—ABCC8—Neuronal System—RAF1—kidney cancer	4.71e-05	0.000894	CbGpPWpGaD
Diazoxide—Nausea—Doxorubicin—kidney cancer	4.68e-05	0.000351	CcSEcCtD
Diazoxide—CA2—Metabolism—CRABP1—kidney cancer	4.63e-05	0.000877	CbGpPWpGaD
Diazoxide—KCNJ11—Neuronal System—RAF1—kidney cancer	4.57e-05	0.000866	CbGpPWpGaD
Diazoxide—KCNMA1—Neuronal System—MAPK1—kidney cancer	4.55e-05	0.000862	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—ABCB1—kidney cancer	4.48e-05	0.000849	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—CA9—kidney cancer	4.44e-05	0.000841	CbGpPWpGaD
Diazoxide—CA1—Metabolism—CRABP1—kidney cancer	4.44e-05	0.000841	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—GSTP1—kidney cancer	4.34e-05	0.000822	CbGpPWpGaD
Diazoxide—CA2—Metabolism—ITPR2—kidney cancer	4.3e-05	0.000815	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—CA9—kidney cancer	4.3e-05	0.000815	CbGpPWpGaD
Diazoxide—CA1—Metabolism—ITPR2—kidney cancer	4.12e-05	0.000782	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—RAF1—kidney cancer	4.12e-05	0.00078	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—ABCB1—kidney cancer	4.11e-05	0.000778	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—GSTM1—kidney cancer	3.99e-05	0.000756	CbGpPWpGaD
Diazoxide—CA2—Metabolism—GSTT1—kidney cancer	3.92e-05	0.000744	CbGpPWpGaD
Diazoxide—CA2—Metabolism—ACHE—kidney cancer	3.92e-05	0.000744	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—CYP1A1—kidney cancer	3.78e-05	0.000716	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—CRABP1—kidney cancer	3.77e-05	0.000715	CbGpPWpGaD
Diazoxide—CA1—Metabolism—GSTT1—kidney cancer	3.76e-05	0.000713	CbGpPWpGaD
Diazoxide—CA1—Metabolism—ACHE—kidney cancer	3.76e-05	0.000713	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.76e-05	0.000713	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—RAF1—kidney cancer	3.76e-05	0.000713	CbGpPWpGaD
Diazoxide—CA2—Metabolism—SCARB1—kidney cancer	3.71e-05	0.000704	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—IL2—kidney cancer	3.69e-05	0.0007	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PTGS1—kidney cancer	3.68e-05	0.000697	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—CRABP1—kidney cancer	3.66e-05	0.000693	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PSMD7—kidney cancer	3.6e-05	0.000683	CbGpPWpGaD
Diazoxide—CA1—Metabolism—SCARB1—kidney cancer	3.56e-05	0.000675	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PTGS1—kidney cancer	3.52e-05	0.000668	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—ITPR2—kidney cancer	3.51e-05	0.000665	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PSMD7—kidney cancer	3.46e-05	0.000655	CbGpPWpGaD
Diazoxide—CA2—Metabolism—BCHE—kidney cancer	3.42e-05	0.000648	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—ITPR2—kidney cancer	3.4e-05	0.000645	CbGpPWpGaD
Diazoxide—CA2—Metabolism—SLC5A5—kidney cancer	3.38e-05	0.00064	CbGpPWpGaD
Diazoxide—CA1—Metabolism—BCHE—kidney cancer	3.28e-05	0.000621	CbGpPWpGaD
Diazoxide—CA2—Metabolism—SLC2A1—kidney cancer	3.26e-05	0.000618	CbGpPWpGaD
Diazoxide—CA1—Metabolism—SLC5A5—kidney cancer	3.24e-05	0.000613	CbGpPWpGaD
Diazoxide—ABCC8—Neuronal System—MAPK1—kidney cancer	3.23e-05	0.000613	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—ACHE—kidney cancer	3.2e-05	0.000606	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—GSTT1—kidney cancer	3.2e-05	0.000606	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—VEGFA—kidney cancer	3.14e-05	0.000595	CbGpPWpGaD
Diazoxide—KCNJ11—Neuronal System—MAPK1—kidney cancer	3.14e-05	0.000594	CbGpPWpGaD
Diazoxide—CA1—Metabolism—SLC2A1—kidney cancer	3.13e-05	0.000592	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—GSTT1—kidney cancer	3.1e-05	0.000588	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—ACHE—kidney cancer	3.1e-05	0.000588	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—SCARB1—kidney cancer	3.03e-05	0.000574	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PTGS1—kidney cancer	3e-05	0.000568	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—MAPK3—kidney cancer	2.97e-05	0.000562	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PSMD7—kidney cancer	2.94e-05	0.000557	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—SCARB1—kidney cancer	2.94e-05	0.000556	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PTGS1—kidney cancer	2.91e-05	0.000551	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PSMD7—kidney cancer	2.85e-05	0.00054	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—MAPK1—kidney cancer	2.82e-05	0.000535	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—POMC—kidney cancer	2.82e-05	0.000534	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—BCHE—kidney cancer	2.79e-05	0.000528	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—SLC5A5—kidney cancer	2.75e-05	0.000522	CbGpPWpGaD
Diazoxide—CA2—Metabolism—GSTP1—kidney cancer	2.72e-05	0.000515	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—BCHE—kidney cancer	2.7e-05	0.000512	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—SLC5A5—kidney cancer	2.67e-05	0.000506	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—KRAS—kidney cancer	2.67e-05	0.000505	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—SLC2A1—kidney cancer	2.66e-05	0.000504	CbGpPWpGaD
Diazoxide—CA1—Metabolism—GSTP1—kidney cancer	2.61e-05	0.000494	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—SLC2A1—kidney cancer	2.58e-05	0.000489	CbGpPWpGaD
Diazoxide—CA2—Metabolism—ABCB1—kidney cancer	2.57e-05	0.000488	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—RAF1—kidney cancer	2.53e-05	0.00048	CbGpPWpGaD
Diazoxide—CA2—Metabolism—GSTM1—kidney cancer	2.5e-05	0.000474	CbGpPWpGaD
Diazoxide—CA1—Metabolism—ABCB1—kidney cancer	2.47e-05	0.000468	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—PIK3CA—kidney cancer	2.45e-05	0.000464	CbGpPWpGaD
Diazoxide—CA1—Metabolism—GSTM1—kidney cancer	2.4e-05	0.000454	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—TP53—kidney cancer	2.37e-05	0.000449	CbGpPWpGaD
Diazoxide—CA2—Metabolism—CYP1A1—kidney cancer	2.37e-05	0.000449	CbGpPWpGaD
Diazoxide—CA1—Metabolism—CYP1A1—kidney cancer	2.27e-05	0.00043	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PTGS2—kidney cancer	2.25e-05	0.000426	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—GSTP1—kidney cancer	2.22e-05	0.00042	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—GSTP1—kidney cancer	2.15e-05	0.000407	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—ABCB1—kidney cancer	2.1e-05	0.000398	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—GSTM1—kidney cancer	2.04e-05	0.000386	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—ABCB1—kidney cancer	2.03e-05	0.000386	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—GSTM1—kidney cancer	1.98e-05	0.000374	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PTEN—kidney cancer	1.96e-05	0.000372	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—CYP1A1—kidney cancer	1.93e-05	0.000366	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—CYP1A1—kidney cancer	1.87e-05	0.000355	CbGpPWpGaD
Diazoxide—CA2—Metabolism—POMC—kidney cancer	1.77e-05	0.000335	CbGpPWpGaD
Diazoxide—CA1—Metabolism—POMC—kidney cancer	1.69e-05	0.000321	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—POMC—kidney cancer	1.44e-05	0.000273	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PTGS2—kidney cancer	1.41e-05	0.000267	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—POMC—kidney cancer	1.4e-05	0.000265	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PIK3CA—kidney cancer	1.38e-05	0.000262	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PTGS2—kidney cancer	1.35e-05	0.000256	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PTEN—kidney cancer	1.23e-05	0.000233	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PTEN—kidney cancer	1.18e-05	0.000223	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PTGS2—kidney cancer	1.15e-05	0.000218	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PTGS2—kidney cancer	1.11e-05	0.000211	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PTEN—kidney cancer	1e-05	0.00019	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PTEN—kidney cancer	9.71e-06	0.000184	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PIK3CA—kidney cancer	8.67e-06	0.000164	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PIK3CA—kidney cancer	8.31e-06	0.000158	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PIK3CA—kidney cancer	7.06e-06	0.000134	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PIK3CA—kidney cancer	6.85e-06	0.00013	CbGpPWpGaD
